Fixed dose oral testosterone undecanoate compositions and use thereof
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Jun 18, 2024
Grant Date -
N/A
app pub date -
Sep 21, 2022
filing date -
Sep 21, 2022
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are effective fixed dose oral testosterone undecanoate compositions for use in regimens without dose titration and methods for treatment of patients in need of testosterone replacement therapy. Also disclosed are criteria for continuation and discontinuation of such regimens, based on single serum T concentration levels measured at a steady state at predetermined times after initiation of said regimen and at a predetermined number of hours after administration of a morning dose of the regimen.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully